← Open Payments lookup

JIBRAN AHMED: Open Payments

NPI 1992311823 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$813 in 30 payments from 9 companies in 2025. Trend: 2023 $79 · 2024 $116 · 2025 $813

Food & beverage: $813
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.4$171
Alkermes, Inc.6$124
Janssen Pharmaceuticals, Inc4$112
Vanda Pharmaceuticals Inc.3$105
ABBVIE INC.5$96
Supernus Pharmaceuticals, Inc.4$91
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$64
Janssen Scientific Affairs, LLC1$34
Takeda Pharmaceuticals U.S.A., Inc.1$15

Products named: REXULTI, SPRAVATO, ARISTADA, HETLIOZ, VRAYLAR, CAPLYTA, Qelbree, TRINTELLIX.

Industry payments across CA — which companies pay providers there.